Alcon (SIX/NYSE:ALC) posted first quarter results today that beat the consensus forecast on Wall Street and maintained its sales and earnings outlook for the rest of the year. The Geneva, Switzerland–based eye care tech company reported profits of $168 million, or $0.34 per share, on sales of $2.2 billion for the three months ended March […]
Vision
LumiThera acquires electrophysiology device maker Diopsys
LumiThera today said it has completed its acquisition of Diopsys for an undisclosed amount. The acquisition of the Pine Brook, N.J.-based electrophysiology medical device maker Diopsys was previously announced on Nov. 11, 2021. Through the deal, Diopsys stockholders will also receive stock in LumiThera, and Diopsys will become a wholly-owned subsidiary of the Seattle-based company. […]
What happens when bionic eye implants suddenly go dark?
An update on the Second Sight Medical Products (NASDAQ:EYES) saga comes to us by way of IEEE Spectrum, offering a cautionary tale for the developers of cutting-edge implants and the patients who place their faith in them. The future remains cloudy for the Los Angeles–based developer of the Argus 2s retinal prosthesis system, which is […]
Staar Surgical beats the Street in Q3, reports order backlog of more than 20,000 lenses
Staar Surgical (NSDQ:STAA) posted third-quarter results after markets closed yesterday that beat the consensus forecast on Wall Street and raised its outlook for the rest of the year. The Lake Forest, California-based implantable lens maker reported profits of $6.0 million, or $0.12 per diluted share, on sales of $58.4 million for the three months ended […]
J&J launches Veritas Vision System for cataract surgery
J&J Vision today announced that it has launched its Veritas Vision System for cataract surgery. J&J designed the phacoemulsification system to address patient safety, surgeon efficiency and comfort. Phacoemulsification is the gold standard treatment during cataract surgery and allows surgeons to effectively emulsify and efficiently remove the eye’s internal lens, according to the company. “In […]
Glaukos beats The Street in Q1 results
Glaukos (NYSE:GKOS) posted first-quarter results that beat the overall consensus on Wall Street. The San Clemente, Calif.-based ophthalmic medical technology company yesterday reported losses of -$16.469 million, or -36¢ per share, on sales of $67.968 million for the three months ended March 31, for a sales growth of 22.83% compared with Q1 2020. Adjusted to […]
Staar Surgical rises on 44% sales growth in Q1 result
Staar Surgical (NSDQ:STAA) posted first-quarter results that beat the overall consensus on Wall Street. The Lake Forest, Calif.-based implantable eye lenses company yesterday reported profits of $4.99 million, or 10¢ per share, on sales of $50.75 million for the three months ended April 2, for a sales growth of 44.24% compared with Q1 2020. Adjusted to […]
9 medical devices you should keep an eye out for in 2021
The medical device industry weathered the COVID-19 pandemic well — and is now set to roll out a host of innovations in 2021. Economists generally expect the U.S. to see a boom as we emerge from the pandemic and resulting recession. Medtech companies appear set to ride the wave this year, with plans to seek approval or […]
Cardiovascular Systems completes minority investment in CarePICS with option to buy
Cardiovascular Systems (NSDQ:CSII) announced that it completed a minority investment and entered into an option agreement to acquire telehealth company CarePICS. CarePICS offers a virtual care platform designed to aid in the treatment of people with peripheral artery disease (PAD), critical limb ischemia (CLI) and lower extremity wounds, according to a news release. The platform […]
Corza Medical set to take on ‘almost monopolistic’ surgical giants
Corza Medical, a new venture forged by the financial firepower of private equity giant GTCR, is looking to become a surgical tool supplier that its executive chairman Greg Lucier says can compete with “almost monopolistic” leaders in the space. To mount the challenge, Corza acquired Surgical Specialties Corp., a supplier of surgical sutures and ophthalmic […]
Alcon slides on missed Q2 earnings
Alcon (NYSE:ALC) shares dipped before hours today on second-quarter results that missed the consensus earnings forecast. The Geneva, Switzerland-based company posted losses of -$422 million, or -86¢ per share, on sales of $1.2 billion for the three months ended June 30, 2020, for an 8.2% bottom-line slide on a sales decline of -36.2%. Adjusted to exclude […]
